{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:52:42Z","timestamp":1788868362164,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1053\/j.seminhematol.2014.05.003","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T12:00:21Z","timestamp":1400155221000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The Meaning and Relevance of B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia"],"prefix":"10.1053","volume":"51","author":[{"given":"Freda K.","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Forconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Packham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2014.05.003_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","article-title":"The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors","volume":"146","author":"Rossi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib2","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2012-01-404681","article-title":"Monoclonal B-cell lymphocytosis: right track or red herring?","volume":"119","author":"Ghia","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385991-4.00001-5","article-title":"Early steps of follicular lymphoma pathogenesis","volume":"111","author":"Roulland","year":"2011","journal-title":"Adv Immunol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2007.06868.x","article-title":"MicroRNAs in the pathogeny of chronic lymphocytic leukaemia","volume":"139","author":"Nicoloso","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib5","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","article-title":"V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia","volume":"100","author":"Krober","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/leu.2012.13","article-title":"Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia","volume":"26","author":"Knight","year":"2012","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib7","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.3109\/10428194.2012.695781","article-title":"Targeting the B cell receptor pathway in chronic lymphocytic leukemia","volume":"53","author":"Davids","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib9","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib10","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1158\/1078-0432.CCR-13-0226","article-title":"Molecular pathways: targeting the microenvironment in chronic lymphocytic leukemia\u2014focus on the B-cell receptor","volume":"20","author":"Ten Hacken","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib12","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","article-title":"Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status","volume":"109","author":"Mockridge","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ni0903-815","article-title":"What is trogocytosis and what is its purpose?","volume":"4","author":"Joly","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature11309","article-title":"Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling","volume":"489","author":"Duhren-von Minden","year":"2012","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.beha.2010.02.001","article-title":"Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells","volume":"23","author":"Damle","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib17","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1349-7006.2011.02046.x","article-title":"Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"102","author":"Igawa","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood-2011-07-370403","article-title":"Surface IgM stimulation induces MEK1\/2-dependent MYC expression in chronic lymphocytic leukemia cells","volume":"119","author":"Krysov","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib19","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood-2013-02-485425","article-title":"Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function","volume":"122","author":"Coelho","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib20","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2119\/molmed.2011.00360","article-title":"Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born\/divided and older\/quiescent cells","volume":"17","author":"Calissano","year":"2011","journal-title":"Mol Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/10428194.2013.803226","article-title":"Ibrutinib in chronic lymphocytic leukemia and B cell malignancies","volume":"55","author":"Brown","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.hoc.2012.12.002","article-title":"Phosphoinositide 3\u05f3-kinase inhibition in chronic lymphocytic leukemia","volume":"27","author":"Davids","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.semcancer.2010.08.004","article-title":"The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia","volume":"20","author":"Packham","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib24","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1182\/blood-2004-07-2669","article-title":"Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells","volume":"105","author":"Petlickovski","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib25","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1182\/blood-2011-07-367417","article-title":"Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia","volume":"119","author":"Paterson","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib26","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","article-title":"Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia","volume":"100","author":"Chen","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","article-title":"Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia","volume":"101","author":"Lanham","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib28","doi-asserted-by":"crossref","first-page":"pii","DOI":"10.13055\/ojhmt_3_S1_03.120221","article-title":"Cell trafficking in chronic lymphocytic leukemia","volume":"3","author":"Davids","year":"2012","journal-title":"Open J Hematol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-065X.2010.00936.x","article-title":"Molecular underpinning of B-cell anergy","volume":"237","author":"Yarkoni","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20080611","article-title":"Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors","volume":"206","author":"Duty","year":"2009","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.leukres.2012.12.019","article-title":"IgD cross-linking induces gene expression profiling changes and enhances apoptosis in chronic lymphocytic leukemia cells","volume":"37","author":"Tavolaro","year":"2013","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2009-03-212837","article-title":"B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406","volume":"114","author":"Quiroga","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib33","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1158\/0008-5472.CAN-08-4750","article-title":"Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease","volume":"69","author":"Vlad","year":"2009","journal-title":"Cancer Res"},{"issue":"3879-88","key":"10.1053\/j.seminhematol.2014.05.003_bib34","first-page":"S1","article-title":"Targeting B-cell anergy in chronic lymphocytic leukemia","volume":"121","author":"Apollonio","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20040920","article-title":"Bruton\u05f3s tyrosine kinase is essential for human B cell tolerance","volume":"200","author":"Ng","year":"2004","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2011.34.7898","article-title":"Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease","volume":"30","author":"Roberts","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","article-title":"In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death","volume":"90","author":"Lam","year":"1997","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cell.2004.05.014","article-title":"Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha\/beta heterodimer","volume":"117","author":"Kraus","year":"2004","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4049\/jimmunol.158.1.235","article-title":"Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features","volume":"158","author":"Johnson","year":"1997","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev.immunol.23.021704.115830","article-title":"Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus","volume":"24","author":"Jung","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib42","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1172\/JCI119433","article-title":"Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)\/IgM+ and CD5(-)\/IgM+ B cells","volume":"99","author":"Brezinschek","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10238-004-0051-2","article-title":"Molecular basis of immunoglobulin variable region gene usage in systemic autoimmunity","volume":"4","author":"Dorner","year":"2005","journal-title":"Clin Exp Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib44","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.4049\/jimmunol.149.7.2337","article-title":"VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities","volume":"149","author":"Pascual","year":"1992","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib45","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.4049\/jimmunol.169.7.3777","article-title":"Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen","volume":"169","author":"Potter","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1006\/jmbi.1996.0110","article-title":"The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3","volume":"256","author":"Li","year":"1996","journal-title":"J Mol Biol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3233\/HAB-1995-6203","article-title":"Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene: a possible link between infection and lupus","volume":"6","author":"Spellerberg","year":"1995","journal-title":"Hum Antibodies Hybridomas"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib48","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.V94.5.1738","article-title":"gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity","volume":"94","author":"Thompsett","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib49","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.V94.5.1755","article-title":"Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin\u05f3s disease","volume":"94","author":"Montesinos-Rongen","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri1853","article-title":"Confounding B-cell defences: lessons from a staphylococcal superantigen","volume":"6","author":"Silverman","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib51","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1073\/pnas.86.15.5913","article-title":"Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia","volume":"86","author":"Kipps","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib52","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","article-title":"Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis","volume":"111","author":"Murray","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib53","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1182\/blood-2007-02-073130","article-title":"Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3","volume":"111","author":"Widhopf","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib54","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2119\/2006-00080.Ghiotto","article-title":"Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia","volume":"12","author":"Ghiotto","year":"2006","journal-title":"Mol Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20040544","article-title":"Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia","volume":"200","author":"Messmer","year":"2004","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib57","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies","volume":"119","author":"Agathangelidis","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2009-06-225813","article-title":"The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL","volume":"115","author":"Forconi","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib59","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.20120833","article-title":"Cellular origin and pathophysiology of chronic lymphocytic leukemia","volume":"209","author":"Seifert","year":"2012","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.imlet.2013.04.007","article-title":"Why do we need IgM memory B cells?","volume":"152","author":"Capolunghi","year":"2013","journal-title":"Immunol Lett"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib61","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.4049\/jimmunol.1103312","article-title":"Innate immunity mediates follicular transport of particulate but not soluble protein antigen","volume":"188","author":"Link","year":"2012","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib62","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","article-title":"A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies","volume":"111","author":"Lanemo Myhrinder","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib63","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood-2006-08-044008","article-title":"Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia","volume":"109","author":"Landgren","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib64","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood-2011-08-374058","article-title":"Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen","volume":"119","author":"Steininger","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib65","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coi.2008.09.001","article-title":"B-cell tolerance checkpoints in health and autoimmunity","volume":"20","author":"Meffre","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib66","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL","volume":"9","author":"Binder","year":"2003","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib67","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2119\/2008-00102.Catera","article-title":"Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation","volume":"14","author":"Catera","year":"2008","journal-title":"Mol Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib68","doi-asserted-by":"crossref","first-page":"e65203","DOI":"10.1371\/journal.pone.0065203","article-title":"IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope","volume":"8","author":"Que","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib69","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1182\/blood-2004-03-0818","article-title":"Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins","volume":"104","author":"Widhopf","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib70","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood-2009-09-244251","article-title":"Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin","volume":"115","author":"Chu","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib71","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood-2011-08-375501","article-title":"The IGHV1-69\/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells","volume":"119","author":"Forconi","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib72","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1182\/blood-2005-04-1483","article-title":"Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes","volume":"107","author":"Kienle","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib73","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.leukres.2006.05.008","article-title":"Chronic lymphocytic leukemia patients with a V1-69 gene rearrangement do not have inferior survival with respect to patients that express other unmutated V(H) genes","volume":"31","author":"Panovska-Stavridis","year":"2007","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib74","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/leu.2013.98","article-title":"Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2","volume":"27","author":"Strefford","year":"2013","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib75","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2013-02-486209","article-title":"Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib76","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI24387","article-title":"Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity","volume":"115","author":"Herve","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib77","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2010.08440.x","article-title":"B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage","volume":"153","author":"Dal-Bo","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib79","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2141.1989.tb07643.x","article-title":"Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity","volume":"72","author":"Stevenson","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib80","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1078-0432.CCR-05-2164","article-title":"Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia","volume":"12","author":"Potter","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib81","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3324\/haematol.2013.086066","article-title":"Chronic lymphocytic leukemia in young (<= 55 years) patients: a comprehensive analysis of prognostic factors and outcomes","volume":"99","author":"Parikh","year":"2014","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib82","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0161-5890(94)00162-T","article-title":"Pattern of usage of the VH4-21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching","volume":"32","author":"Chapman","year":"1995","journal-title":"Mol Immunol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib83","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/leu.2008.379","article-title":"Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors","volume":"23","author":"Kostareli","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib84","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clml.2012.01.009","article-title":"IGHV3-21 gene frequency in a Swedish cohort of patients with newly diagnosed chronic lymphocytic leukemia","volume":"12","author":"Cahill","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib85","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2002-11-3485","article-title":"Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope","volume":"101","author":"Tobin","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib86","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1182\/blood-2006-10-051110","article-title":"Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study","volume":"109","author":"Bomben","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib87","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20121801","article-title":"A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi","volume":"210","author":"Hoogeboom","year":"2013","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib88","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.semcancer.2010.09.004","article-title":"Antigens in chronic lymphocytic leukemia\u2014implications for cell origin and leukemogenesis","volume":"20","author":"Rosen","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib89","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/leu.2012.238","article-title":"A novel chronic lymphocytic leukemia subset expressing mutated IGHV3-7-encoded rheumatoid factor B-cell receptors that are functionally proficient","volume":"27","author":"Hoogeboom","year":"2013","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib90","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood.V78.3.581.581","article-title":"Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas","volume":"78","author":"Dighiero","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib91","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.leukres.2010.10.022","article-title":"CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL","volume":"35","author":"Majid","year":"2011","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminhematol.2014.05.003_bib92","unstructured":"Pepper C. Unpublished data."}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196314000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196314000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:23:48Z","timestamp":1758522228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196314000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0037196314000298"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2014.05.003","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Meaning and Relevance of B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2014.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}